Contrast-Induced Nephropathy

CIN Basics - Kidney Contrast Chaos

• Definition: Acute kidney injury (AKI) occurring after intravascular administration of iodinated contrast media.
• Diagnostic Criteria (48-72h post-contrast):
  • Rise in serum creatinine (SCr) by ≥0.5 mg/dL (≥44 µmol/L)
  • OR ≥25% increase in SCr from baseline.
• Pathophysiology: Multifactorial:
  • Direct tubular toxicity (osmotic load, chemical).
  • Renal ischemia (medullary hypoxia, vasoconstriction).
  • Oxidative stress & reactive oxygen species (ROS).

⭐ Most cases of CIN are non-oliguric and reversible, typically resolving within 1-2 weeks.

Risk Factors - CIN Danger Zones

• Patient Factors:
  • Pre-existing CKD (eGFR <60 mL/min/1.73m²; most significant)
  • Diabetes Mellitus (esp. nephropathy)
  • Dehydration/Volume depletion
  • Age >75 yrs
  • Congestive Heart Failure (CHF), Hypotension, Anemia
• Procedure Factors:
  • High contrast volume
  • Type: High-osmolar (HOCM) > Low-osmolar (LOCM) > Iso-osmolar (IOCM)
  • Intra-arterial > Intravenous admin
  • Multiple exposures (<72h)
• Concomitant Medications:
  • Nephrotoxic drugs (NSAIDs, aminoglycosides, amphotericin B, diuretics if causing volume depletion)
• Mehran Score: Risk stratification tool (key: hypotension, IABP, CHF, age >75, anemia, diabetes, contrast volume, SCr >1.5 mg/dL or eGFR <60).

⭐ Pre-existing Chronic Kidney Disease (CKD), particularly an eGFR <60 mL/min/1.73m², is the single most important risk factor for developing CIN.

Clinical Presentation & Diagnosis - Spotting Kidney Strain

• Often asymptomatic. Non-oliguric renal failure (urine output >500 mL/day) is more common.
• Serum Creatinine (SCr) Timeline:
  • Rises: 24-48 hours post-contrast.
  • Peaks: 3-5 days.
  • Resolves: 7-14 days.
• Urinalysis: May show transient proteinuria, renal tubular epithelial cells, muddy brown granular casts (indicative of ATN).
  • FENa: Typically <1% (prerenal) or >1-2% (established ATN).
• Differential Diagnosis: Atheroembolic renal disease (later onset: 1-2 weeks, associated with livedo reticularis, eosinophilia).

⭐ Non-oliguric renal failure is more common than oliguric (<500 mL/day urine output) in Contrast-Induced Nephropathy (CIN).

Prevention Strategies - Guarding the Glomeruli

• Identify high-risk patients.
• Periprocedural Hydration: Cornerstone of CIN prevention.
  • IV: Isotonic crystalloids (0.9% NaCl / Ringer's Lactate) at 1-1.5 mL/kg/hr.
  • Timing: 3-6 hours pre-procedure, continue 4-6 hours post-procedure (up to 12-24 hours in very high-risk cases).
  • Oral hydration if IV access is difficult and patient is not NPO.
• Contrast Media Choice & Volume:
  • Use Low-Osmolar (LOCM) or Iso-Osmolar Contrast Media (IOCM). Avoid High-Osmolar (HOCM).
  • Minimize contrast volume to the lowest diagnostically adequate dose.
• Medication Management:
  • Temporarily discontinue nephrotoxic drugs (e.g., NSAIDs, aminoglycosides).
  • Metformin: Hold on the day of procedure and for 48 hours afterward; restart only after confirming stable renal function.
• Adjunctive Measures (Consider):
  • N-acetylcysteine (NAC): 600-1200 mg PO BID for 2 days (day before and day of procedure). Evidence is controversial. 📌 NAC for Nephron Aid & Care.
  • Sodium Bicarbonate infusion: Alternative hydration strategy to alkalinize tubular fluid; evidence mixed.
  • Statins: Continue if patient is already on statin therapy.

⭐ Periprocedural IV hydration with isotonic saline is the most crucial and evidence-backed strategy for CIN prevention in high-risk patients.

Management - Kidney Rescue Plan

• No specific antidote; management is primarily supportive.
• Maintain hemodynamic stability, hydration, and electrolyte balance.
• Monitor renal function (SCr, BUN, urine output) daily.
• Avoid further nephrotoxic insults (e.g., NSAIDs, repeat contrast).
• Renal Replacement Therapy (RRT) for severe AKI complications (e.g., refractory hyperkalemia, uremia, fluid overload).

⭐ CIN is usually transient and reversible, but its development is associated with increased morbidity and mortality, especially in high-risk patients or those with severe AKI.

High‑Yield Points - ⚡ Biggest Takeaways

• CIN Definition: ↑ Serum Creatinine by >0.5 mg/dL or >25% baseline, 48-72 hrs post-contrast.
• Highest Risk: Patients with CKD (especially eGFR <30 mL/min/1.73m²), diabetes mellitus, dehydration.
• Contrast Factors: High osmolar contrast media (HOCM), large contrast volume, and repeat doses significantly ↑ risk.
• Prevention: IV hydration (isotonic saline pre- and post-procedure), use low/iso-osmolar contrast (LOCM/IOCM), minimize volume.
• N-acetylcysteine (NAC): Role controversial; consider for high-risk patients. Stop other nephrotoxic drugs (e.g., NSAIDs).
• Clinical Course: Usually transient, non-oliguric Acute Kidney Injury (AKI); peaks 3-5 days, typically resolves in 7-10 days.
• Mehran Score: Often used for risk stratification prior to contrast administration in cardiac procedures.